Sanofi eyes German insulin investment of up to 1.6 bln, source says - Reuters
| INSL Stock | ILS 196.00 20.90 9.64% |
About 61% of Insuline Medical's investor base is looking to short. The analysis of current outlook of investing in Insuline Medical suggests that many traders are alarmed regarding Insuline Medical's prospects. The current market sentiment, together with Insuline Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Insuline Medical stock news signals to limit their universe of possible portfolio assets.
Insuline |
Sanofi eyes German insulin investment of up to 1.6 bln, source says Reuters
Read at news.google.com
 |
Insuline Medical Fundamental Analysis
We analyze Insuline Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insuline Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insuline Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Insuline Medical is rated third overall in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Insuline Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Insuline Medical stock to make a market-neutral strategy. Peer analysis of Insuline Medical could also be used in its relative valuation, which is a method of valuing Insuline Medical by comparing valuation metrics with similar companies.
Peers
Insuline Medical Related Equities
| EMITF | Elbit Imaging | 3.11 | ||||
| HUMX | Human Xtensions | 0.69 | ||||
| BIOV | Bio View | 0.35 | ||||
| ENDY | Endymed | 0.34 | ||||
| INCR | Intercure | 0.32 | ||||
| EPIT | Epitomee Medical | 1.10 | ||||
| SOFW | Sofwave Medical | 2.02 | ||||
| INSL | Insuline Medical | 9.64 |
Complementary Tools for Insuline Stock analysis
When running Insuline Medical's price analysis, check to measure Insuline Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insuline Medical is operating at the current time. Most of Insuline Medical's value examination focuses on studying past and present price action to predict the probability of Insuline Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insuline Medical's price. Additionally, you may evaluate how the addition of Insuline Medical to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |